Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 65.2B 9.73B 8.48B 8.01B 7.27B 13.63B 933B 13.68B 95.95B 37.03B 475B 36.54B 35.73B 1,527B | P/E 2026 * |
49.3x | P/E 2027 * | 37.2x |
|---|---|---|---|---|---|
| Enterprise Value | 60.52B 9.03B 7.87B 7.44B 6.75B 12.65B 867B 12.7B 89.07B 34.37B 441B 33.92B 33.17B 1,418B | EV / Sales 2026 * |
7.48x | EV / Sales 2027 * | 6.28x |
| Free-Float |
61.13% | Yield 2026 * |
0.73% | Yield 2027 * | 0.98% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 07/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 19/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 18/07/2011 |
Hao Hong
CHM | Chairman | 70 | 07/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 18/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 9.73B | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.03% | +3.26% | +25.25% | +45.35% | 400.19B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.21B 1.05B 994M 902M 1.69B 116B 1.7B 11.9B 4.59B 58.88B 4.53B 4.43B 189B | 9.8B 1.46B 1.28B 1.2B 1.09B 2.05B 140B 2.06B 14.43B 5.57B 71.36B 5.49B 5.37B 230B |
| Net income | 1.41B 211M 184M 173M 157M 295M 20.21B 296M 2.08B 802M 10.28B 791M 774M 33.07B | 1.82B 271M 236M 223M 203M 380M 26.02B 381M 2.67B 1.03B 13.23B 1.02B 996M 42.57B |
| Net Debt | -4.67B -697M -608M -574M -521M -977M -66.91B -981M -6.88B -2.65B -34.02B -2.62B -2.56B -109B | -3.66B -546M -476M -449M -408M -764M -52.34B -767M -5.38B -2.08B -26.61B -2.05B -2B -85.63B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
